FDA Clearance Tracker · K181661
QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR System
Last checked: Nov 20, 2026Latest source record: Feb 13, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Feb 13, 2019
Substantially Equivalent
Time to decision
233 days
Received Jun 25, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K181661
- Device name
- QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR System
- Applicant
- Bio-Rad Laboratories, Inc.
- Applicant location
- Pleasanton, CA
- Received
- Jun 25, 2018
- Decided
- Feb 13, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Bcr/Abl1 Monitoring Test (OYX)
- Device class
- Class II
- Regulation
- 21 CFR 866.6060
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OYX. The earliest in FDA's data is DEN160003, decided Jul 22, 2016.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K181661
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bio-Rad Laboratories, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K171664 · Decided Sep 13, 2017 · 100 days after receipt
Device type: Abnormal Hemoglobin Quantitation (GKA) · Laboratory Medicine & Pathology
K161687 · Decided Oct 14, 2016 · 119 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
K151321 · Decided Dec 9, 2015 · 205 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.